The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (Study P04445AM2)(COMPLETED)
This study has been completed.
Study NCT00266799
Information provided by Schering-Plough
First Received on December 15, 2005.
Last Updated on October 10, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
